Related Experiment Videos
[Veterinary pharmacotherapy: from retrospect to future expectations].
Tijdschrift Voor Diergeneeskunde
|July 15, 1987
Summary
This review traces the evolution of veterinary pharmacotherapy from early apomorphine research to modern biotechnology. It highlights advancements in drug development and the potential of recombinant DNA techniques for future pharmacological studies.
Area of Science:
- Pharmacology
- Veterinary Medicine
- Biotechnology
Context:
- Historical review of apomorphine (1875) and the development of rational pharmacotherapy.
- Progress in veterinary pharmacotherapy during the 1960s and 1970s.
- Introduction of recent veterinary drugs like aditoprim, florfenicol, and flumazenil.
Purpose:
- To provide a comprehensive overview of the historical development and recent advancements in veterinary pharmacotherapy.
- To explore the emerging role of biotechnology, specifically recombinant DNA techniques, in veterinary medicine.
Summary:
- The review discusses the historical trajectory of pharmacotherapy, starting with early research on apomorphine.
- It details the progress in veterinary pharmacotherapy, including key drug introductions.
- The potential of biotechnology, such as recombinant DNA-produced polypeptides (interferons, interleukins, somatotropins) and receptor proteins, is examined for future applications.
Impact:
- Provides insights into the evolution of veterinary drug development and treatment strategies.
- Highlights the significance of biotechnology in advancing veterinary pharmacology and zootechnics.
- Suggests new avenues for pharmacological research through recombinant DNA technology and receptor protein synthesis.